Bhatti ABH, Hameed Z, Almas T, Riyaz S, Ahmad A. Multivisceral central pancreatectomy for pancreatic neuroendocrine tumor: A case report on a novel surgical technique.
Int J Surg Case Rep 2021;
78:292-295. [PMID:
33383284 PMCID:
PMC7777176 DOI:
10.1016/j.ijscr.2020.12.025]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2020] [Revised: 12/10/2020] [Accepted: 12/11/2020] [Indexed: 02/08/2023] Open
Abstract
INTRODUCTION
Central pancreatectomy (CP) is considered a viable alternative to subtotal distal pancreatectomy, for lesions involving the neck or proximal pancreatic body. Multivisceral central pancreatectomy (MVCP) for locally advanced tumors of the pancreatic body remains unreported.
PRESENTATION OF CASE
We hereby report a case of locally advanced pancreatic neuroendocrine tumor (NET) with gastric involvement. The patient underwent successful central pancreatectomy with subtotal gastrectomy for locally advanced NET of the pancreas. In the follow up period, relevant complications like pancreatic insufficiency or pancreatic fistula were not encountered. The patient is doing well more than ten months after resection.
DISCUSSION
A MVCP can be considered in patients with limited pancreatic involvement, as long as sufficient pancreatic parenchyma can be preserved. Additional organ involvement mandating resection should not be considered a contra indication to this procedure. With careful surgical planning and meticulous technique, risk of post operative complications after MVCP can be minimized with added benefit of long term endocrine and exocrine integrity.
CONCLUSIONS
CP is a viable alternative and can be performed with adjacent organ resection, with acceptable post operative outcomes.
Collapse